Latest Articles
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer - OncLive
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer OncLive
Published: Jan. 31, 2025, 8:48 p.m.
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer - OncLive
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer OncLive
Published: Jan. 30, 2025, 10:29 p.m.
Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy - Frontiers
Unveiling Immunogenic Characteristics and Neoantigens in Endometrial Cancer with POLE Hotspot Mutations for Improved Immunotherapy Frontiers
Published: Jan. 6, 2025, 6:36 p.m.
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides - Nature.com
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides Nature.com
Published: Dec. 21, 2024, 9:20 a.m.
The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway | Cell Death & Disease - Nature.com
The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway | Cell Death & Disease Nature.com
Published: Jan. 18, 2024, 8 a.m.
Link copied to clipboard!